Epic Pharma LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Epic Pharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10831
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug development company that manufactures and develops generic prescription drugs. The company’s products include amlodipine besylate, citalopram, betaxolol, nicardipine hydrochloride, guanfacine hydrochloride, meperidine hydrochloride, flacoxate hydrochloride, sulindac, and ursodiol, among others. It offers services such as encapsulation, tableting, contract manufacturing, packaging and testing services, among others. Epic Pharma provides its products in the dosage forms of capsules, powder, and tablet forms. The company markets its products through its network of distributors located across the US. The company operates through its manufacturing facility located in the US. Epic Pharma is headquartered in New York, the US.

Epic Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Epic Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 10
Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 11
Acquisition 12
Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 12
Epic Pharma LLC – Key Competitors 14
Epic Pharma LLC – Key Employees 15
Epic Pharma LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Epic Pharma LLC, Pharmaceuticals & Healthcare, Key Facts 2
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Epic Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Epic Pharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 10
Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 11
Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 12
Epic Pharma LLC, Key Competitors 14
Epic Pharma LLC, Key Employees 15

List of Figures
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Epic Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Epic Pharma LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Golden Biotechnology Corp. (4132):企業の財務及び戦略的SWOT分析
    Summary Golden Biotechnology Corp. (Golden Biotech) is a biotechnology company that develops drugs. The company develops and commercializes drugs and herbal supplements to prevent and treat diseases. It discovers new drugs for anti-atherosclerosis and anti-cancer from the screening platforms. Golden …
  • Gas Natural Fenosa:企業のM&A・事業提携・投資動向
    Gas Natural Fenosa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gas Natural Fenosa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Screen Holdings Co., Ltd. (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • Vornado Realty Trustの企業概要及び財務/SWOT分析
    Vornado Realty Trust Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Vornado Realty Trust annual and quarterly forecasts made by stock market experts. The report also enables …
  • Ausenco Limitedの企業概要及び財務/SWOT分析
    Ausenco Limited Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Ausenco Limited annual and quarterly forecasts made by stock market experts. The report also enables direct co …
  • China Foods Limited:企業の戦略・SWOT・財務分析
    SummaryChina Foods Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Feelgood Svenska AB (FEEL):企業概要、財務及び戦略的SWOT分析
    Summary Feelgood Svenska AB (Feelgood Svenska) is a healthcare service provider. The company provides healthcare services to businesses, organizations, and individuals. It offers medical services, primary care, exercise, and physical therapy. Feelgood Svenska offers services in the areas of sustaina …
  • JTEKT Corporation (6473):企業財務及び戦略的SWOT分析
    Summary JTEKT Corporation (JTEKT) is an industrial equipment company that develops and markets steering systems. The company provides products such as automotive components, sensors, bearings and machine tools and mechatronics. Its automotive components include steering systems, drive line systems a …
  • UMC Utrecht Holding BV:製薬・医療:M&Aディール及び事業提携情報
    Summary UMC Utrecht Holding BV (Utrecht Holding), a subsidiary of University Medical Center Utrecht, is a technology transfer service provider. The center concentrates on utilisation and commercialisation of academic research. Its activities include screening and scouting; advising on knowledge util …
  • NeuroSearch AS (NEUR):企業の財務・戦略的SWOT分析
    NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MerLion Pharmaceuticals Pte. Ltd:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MerLion Pharmaceuticals Pte. Lt …
  • Ariel Corp:企業の戦略的SWOT分析
    Ariel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Juniper Pharmaceuticals Inc (JNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature's chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of …
  • MUFG Americas Holdings Corporation:企業の戦略・SWOT・財務分析
    SummaryMUFG Americas Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Vitopel S.A.:企業の戦略・SWOT・財務分析
    SummaryVitopel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • eResearchTechnology, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary eResearchTechnology, Inc. (ERT) is a technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs). It offers services which assist these companies to achieve their drug development and healthcare objectives. ERT uses …
  • National Taiwan University Hospital(製薬・医療分野):企業M&A動向
    Summary National Taiwan University Hospital (NTUH) is a healthcare services provider. The hospital conducts biomedical and clinical research. Its research activities include program projects, community-based intervention programs, multicenter controlled clinical trials, research and development proj …
  • Willis Towers Watson Public Ltd Co:戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆